Anti-VEGF Agents and Glaucoma Filtering Surgery.
作者信息
Daneshvar Ramin
机构信息
Eye Research Center & Cornea Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
出版信息
J Ophthalmic Vis Res. 2013 Apr;8(2):182-6.
Abstract
摘要
相似文献
1
Anti-VEGF Agents and Glaucoma Filtering Surgery.
J Ophthalmic Vis Res. 2013 Apr;8(2):182-6.
2
[Late and sustained intraocular pressure elevation related to intravitreal anti-VEGF injections: Cases requiring filtering surgery (French translation of the article)].
J Fr Ophtalmol. 2018 Nov;41(9):789-801. doi: 10.1016/j.jfo.2018.03.014. Epub 2018 Oct 19.
3
Assessing the role of ranibizumab in improving the outcome of glaucoma filtering surgery and neovascular glaucoma.
Expert Opin Biol Ther. 2018 Jun;18(6):719-724. doi: 10.1080/14712598.2018.1479395. Epub 2018 May 24.
4
[Application of anti-VEGF agents in treatment of neovascular glaucoma and anti-scarring in filtering surgery].
Zhonghua Yan Ke Za Zhi. 2015 Apr;51(4):314-8.
5
Effect of prior glaucoma surgery on intraocular pressure immediately after anti-vascular endothelial growth factor injection.
Graefes Arch Clin Exp Ophthalmol. 2019 Nov;257(11):2489-2494. doi: 10.1007/s00417-019-04431-x. Epub 2019 Aug 6.
6
Current and Future Techniques in Wound Healing Modulation after Glaucoma Filtering Surgeries.
Open Ophthalmol J. 2016 Feb 29;10:68-85. doi: 10.2174/1874364101610010068. eCollection 2016.
7
[Needle revision of late failing filtering blebs after glaucoma surgery].
Arch Soc Esp Oftalmol. 2006 Sep;81(9):517-22. doi: 10.4321/s0365-66912006000900006.
8
[Ahmed valve in glaucoma surgery].
Vestn Oftalmol. 2017;133(6):126-130. doi: 10.17116/oftalma20171336126-130.
9
[Anti-VEGF-agents in treatment of neovascular glaucoma].
Vestn Oftalmol. 2012 Sep-Oct;128(5):50-3.
10
Glaucoma filtration surgery following sustained elevation of intraocular pressure secondary to intravitreal anti-VEGF injections.
Ophthalmic Surg Lasers Imaging. 2012 Jul 1;43(4):328-34. doi: 10.3928/15428877-20120618-01.
引用本文的文献
1
Plasma rich in growth factors (PRGF) technology as adjuvant to Ab Externo trabeculectomy.
Int Ophthalmol. 2024 Jul 22;44(1):332. doi: 10.1007/s10792-024-03253-z.
2
The Effect of a Triple Combination of Bevacizumab, Sodium Hyaluronate and a Collagen Matrix Implant in a Trabeculectomy Animal Model.
Pharmaceutics. 2021 Jun 17;13(6):896. doi: 10.3390/pharmaceutics13060896.
3
Suppression of Human Tenon Fibroblast Cell Proliferation by Lentivirus-Mediated VEGF Small Hairpin RNA.
J Ophthalmol. 2017;2017:7982051. doi: 10.1155/2017/7982051. Epub 2017 Jan 11.
4
Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma.
Adv Ther. 2017 Feb;34(2):378-395. doi: 10.1007/s12325-016-0461-z. Epub 2016 Dec 20.
5
The era of anti-vascular endothelial growth factor (VEGF) drugs in ophthalmology, VEGF and anti-VEGF therapy.
Cent Eur J Immunol. 2016;41(3):311-316. doi: 10.5114/ceji.2016.63132. Epub 2016 Oct 25.
6
Exploring the Molecular Interactions of 7,8-Dihydroxyflavone and Its Derivatives with TrkB and VEGFR2 Proteins.
Int J Mol Sci. 2015 Sep 3;16(9):21087-108. doi: 10.3390/ijms160921087.
7
Subconjunctival bevacizumab to augment trabeculectomy with mitomycin C in the management of failed glaucoma surgery.
Clin Ophthalmol. 2014 Sep 15;8:1745-55. doi: 10.2147/OPTH.S67730. eCollection 2014.
本文引用的文献
1
Role of subconjunctival bevacizumab as an adjuvant to primary trabeculectomy: a prospective randomized comparative 1-year follow-up study.
J Glaucoma. 2015 Jan;24(1):1-8. doi: 10.1097/IJG.0b013e318287abf3.
2
Intracameral ranibizumab and subsequent mitomycin C augmented trabeculectomy in neovascular glaucoma.
J Glaucoma. 2014 Sep;23(7):437-40. doi: 10.1097/IJG.0b013e3182946398.
3
Level of vascular endothelial growth factor in tenon tissue and results of glaucoma surgery.
Arch Ophthalmol. 2012 Jun;130(6):685-9. doi: 10.1001/archophthalmol.2011.2799.
4
Subconjunctival bevacizumab versus mitomycin C adjunctive to trabeculectomy.
Am J Ophthalmol. 2012 Feb;153(2):352-357.e1. doi: 10.1016/j.ajo.2011.08.005. Epub 2011 Oct 7.
5
The role of different VEGF isoforms in scar formation after glaucoma filtration surgery.
Exp Eye Res. 2011 Nov;93(5):689-99. doi: 10.1016/j.exer.2011.08.016. Epub 2011 Sep 1.
6
Intravitreal bevacizumab with or without mitomycin C trabeculectomy in the treatment of neovascular glaucoma.
Clin Ophthalmol. 2011;5:841-5. doi: 10.2147/OPTH.S21453. Epub 2011 Jun 22.
7
Low-dose subconjunctival bevacizumab to augment trabeculectomy for glaucoma.
Clin Ophthalmol. 2011;5:797-800. doi: 10.2147/OPTH.S17896. Epub 2011 Jun 15.
8
Comparison of the use of 5-fluorouracil and bevacizumab in primary trabeculectomy: results at 1 year.
Clin Exp Ophthalmol. 2012 May-Jun;40(4):e135-42. doi: 10.1111/j.1442-9071.2011.02608.x.
9
Safety and efficacy of using off-label bevacizumab versus mitomycin C to prevent bleb failure in a single-site phacotrabeculectomy by a randomized controlled clinical trial.
J Glaucoma. 2012 Sep;21(7):450-9. doi: 10.1097/IJG.0b013e31821826b2.
10
One-year results of intravitreal bevacizumab as an adjunct to trabeculectomy for neovascular glaucoma in eyes with previous vitrectomy.
Eye (Lond). 2011 May;25(5):658-9. doi: 10.1038/eye.2011.58. Epub 2011 Mar 18.
Zotero 插件